[title missed]

Corresponding author: 韦蔚琦, 1780138369@qq.com

DOI: 10.12201/bmr.202601.00069

•  

  Abstract: [abstract missed]

  Key words: ; ; ; ; 

  Submit time: 26 January 2026

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Shi Shenghong. . 2024. doi: 10.12201/bmr.202411.00062

  ZHAO Qing, JING Jiangxin. Advances in the application of ultrasound-based radiomics in predicting molecular typing of breast cancer. 2024. doi: 10.12201/bmr.202410.00040

  Zhaoqing, Jing Jiangxin. Progress and status of ultrasound imaging in breast cancer. 2024. doi: 10.12201/bmr.202412.00053

  鲍呈洋, yangyingtao. Factors Influencing the Efficacy of Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer. 2025. doi: 10.12201/bmr.202511.00048

  WEI Yuguo, LIU Liqiu, XU Zhuliang, WANG Guoyu. Application value of biparametric magnetic resonance radiomics combined with prostate-specific antigen density in Gleason grade group of prostate cancer. 2024. doi: 10.12201/bmr.202406.00029

  Yao Genwu, Wang Yanwei, Guo Jinyi, Li Lulu, Dang Wenbo, Song Ailin. Advances in single-cell sequencing in the breast cancer. 2024. doi: 10.12201/bmr.202407.00053

  Advances in Research on the Aggressive Nature of PitNETs Using Serological Markers in Combination with Imaging Biomarkers. 2025. doi: 10.12201/bmr.202508.00037

  yuguozheng. Research Advances in Metadherin (MTDH) in Breast Cancer. 2026. doi: 10.12201/bmr.202601.00039

  朱潇, DuanYi, Hao Lu. . 2025. doi: 10.12201/bmr.202511.00014

  杨鹤, zhaoqing, zhaihong. . 2024. doi: 10.12201/bmr.202411.00032

• ID	Submit time	Number	Download
  1	2025-12-24	10.12201/bmr.202601.00069V1	Download

• Public  Anonymous  To author only Submit Comments